TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice

Oncology Research

Volumn 16, Issue 8, 2007, Pages 351-359

  Gupta, Bhawna ^a   Levchenko, Tatiana S ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Brain tumor; Gene delivery; Intracranial; Liposome; TAT peptide; U 87 MG astrocytoma

Indexed keywords

DNA; GREEN FLUORESCENT PROTEIN; LIPOPLEX; LIPOSOME; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; COMPLEX FORMATION; CONTROLLED STUDY; DRUG FORMULATION; GENE DELIVERY SYSTEM; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR XENOGRAFT;

EID: 34548664578     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783980946     Document Type: Article

References (46)

1. Brandes, A. A.; Fiorentino, M. V. The role of chemotherapy in recurrent malignant gliomas: An overview. Cancer Invest. 14:551-559; 1996.
2. Ichikawa, T.; Tamiya, T.; Adachi, Y.; Ono, Y.; Matsumoto, K.; Furuta, T.; Yoshida, Y.; Hamada, H.; Ohmoto, T. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. Cancer Gene Ther. 7:74-82; 2000.
3. Pulkkanen, K. J.; Yla-Herttuala, S. Gene therapy for malignant glioma: Current clinical status. Mol. Ther. 12:585-598; 2005.
4. Castro, M. G.; Cowen, R.; Williamson, I. K.; David, A.; Jimenez-Dalmaroni, M. J.; Yuan, X.; Bigliari, A.; Williams, J. C.; Hu, J.; Lowenstein, P. R. Current and future strategies for the treatment of malignant brain tumors. Pharmacol. Ther. 98:71-108; 2003.
5. Hamel, W.; Westphal, M. Gene therapy of gliomas. Acta Neurochir. Suppl. 88:125-135; 2003.
6. Weyerbrock, A.; Oldfield, E. H. Gene transfer technologies for malignant gliomas. Curr. Opin. Oncol. 11:168-173; 1999.
7. Higgins, R. J.; McKisic, M.; Dickinson, P. J.; Jimenez, D. F.; Dow, S. W.; Tripp, L. D.; LeCouteur, R. A. Growth inhibition of an orthotopic glioblastoma in immunocompetent mice by cationic lipid-DNA complexes. Cancer Immunol. Immunother. 53:338-344; 2004.
8. Yagi, K.; Hayashi, Y.; Ishida, N.; Ohbayashi, M.; Ohishi, N.; Mizuno, M.; Yoshida. J. Interferon-beta endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: Cytocidal effect on glioma transplanted into nude mouse brain. Biochem. Mol. Biol. Int. 32:167-171; 1994.
9. Yagi, K.; Ohishi, N.; Hamada, A.; Shamoto, M.; Ohbayashi, M.; Ishida, N.; Nagata, A.; Kanazawa, S.; Nishikimi, M. Basic study on gene therapy of human malignant glioma by use of the cationic multilamellar liposome-entrapped human interferon beta gene. Hum. Gene Ther. 10:1975-1982; 1999.
10. Natsume, A.; Tsujimura, K.; Mizuno, M.; Takahashi, T.; Yoshida, J. IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma. J. Neurooncol. 47:117-124; 2000.
11. MacKay, J. A.; Deen, D. F.; Szoka, Jr., F. C. Distribution in brain of liposomes after convection enhanced delivery: modulation by particle charge, particle diameter, and presence of steric coating. Brain Res. 1035:139-153; 2005.
12. da Cruz, M. T.; Cardoso, A. L.; de Almeida, L. P.; Simoes, S.; de Lima, M. C. Tf-lipoplex-mediated NGF gene transfer to the CNS: Neuronal protection and recovery in an excitotoxic model of brain injury. Gene Ther. 12:1242-1252; 2005.
13. da Cruz, M. T.; Simoes, S.; de Lima, M. C. Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons. Exp. Neurol. 187:65-75; 2004.
14. Mizuno, M.; Yoshida, J. Effect of human interferon beta gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells. Cancer Immunol. Immunother. 47:227-232; 1998.
15. Wadia, J. S.; Stan, R. V.; Dowdy, S. F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10:310-315; 2004.
16. Schwarze, S. R.; Hruska, K. A.; Dowdy, S. F. Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol. 10:290-295; 2000.
17. Torchilin, V. P.; Levchenko, T. S.; Rammohan, R.; Volodina, N.; Papahadjopoulos-Sternberg, B.; D'Souza, G. G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. USA 100:1972-1977; 2003.
18. Lasch, J.; Weissig, V.; Brandl, M. Preparation of liposomes. In: Torchilin, V. P.; Weissig, V., eds. Liposomes: A practical approach. New York: Oxford University Press; 2003:3-29.
19. Torchilin, V. P.; Levchenko, T. S.; Lukyanov, A. N.; Khaw, B. A.; Klibanov, A. L.; Rammohan, R.; Samokhin, G. P.; Whiteman, K. R. p-Nitrophenylcarbonyl-PEG-PE-liposomes: Fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim. Biophys. Acta 1511:397-411; 2001.
20. Zanjani, E. D.; Anderson, W. F. Prospects for in utero human gene therapy. Science 285:2084-2088; 1999.
21. McCormick, F. Cancer gene therapy: Fringe or cutting edge? Nat. Rev. Cancer 1:130-141; 2001.
22. Feigner, P. L.; Gadek, T. R.; Holm, M.; Roman, R.; Chan, H. W.; Wenz, M.; Northrop, J. P.; Ringold, G. M.; Danielsen, M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84:7413-7417; 1987.
23. Feigner, P. L.; Ringold, G. M. Cationic liposome-mediated transfection. Nature 337:387-388; 1989.
24. Harada, K.; Yoshida, J.; Mizuno, M.; Kurisu, K.; Uozumi, T. Growth inhibition of intracerebral rat glioma by transfection-induced human interferon-beta. J. Surg. Oncol. 59:105-109; 1995.
25. von Eckardstein, K. L.; Patt, S.; Zhu, J.; Zhang, L.; Cervos-Navarro, J.; Reszka, R. Short-term neuropathological aspects of in vivo suicide gene transfer to the F98 rat glioblastoma using liposomal and viral vectors. Histol. Histopathol. 16:735-744; 2001.
26. Zhu, J.; Zhang, L.; Hanisch, U. K.; Feigner, P. L.; Reszka, R. A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy. Gene Ther. 3:472-476; 1996.
27. Mizuno, M.; Ryuke, Y.; Yoshida, J. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models. Cancer Gene Ther. 9:825-829; 2002.
28. Voges, J.; Weber, F.; Reszka, R.; Sturm, V.; Jacobs, A.; Heiss, W. D.; Wiestler, O.; Kapp, J. F. Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme. Hum. Gene Ther. 13:675-685; 2002.
29. Reszka, R. C.; Jacobs, A.; Voges, J. Liposome-mediated suicide gene therapy in humans. Methods Enzymol. 391:200-208; 2005.
30. Voges, J.; Reszka, R.; Gossmann, A.; Dittmar, C.; Richter, R.; Garlip, G.; Kracht, L.; Coenen, H. H.; Sturm, V.; Wienhard, K.; Heiss, W. D.; Jacobs, A. H. Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann. Neurol. 54:479-487; 2003.
31. Jacobs, A.; Voges, J.; Reszka, R.; Lercher, M.; Gossmann, A.; Kracht, L.; Kaestle, C.; Wagner, R.; Wienhard, K.; Heiss, W. D. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358:727-729; 2001.
32. Yoshida, J.; Mizuno, M. Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma. J. Neurooncol. 65:261-267; 2003.
33. Yoshida, J.; Mizuno, M.; Fujii, M.; Kajita, Y.; Nakahara, N.; Hatano, M.; Saito, R.; Nobayashi, M.; Wakabayashi, T. Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes. Hum. Gene Ther. 15:77-86; 2004.
34. Huynh, G. H.; Deen, D. F.; Szoka, Jr., F. C. Barriers to carrier mediated drug and gene delivery to brain tumors. J. Control Release 110:236-259; 2006.
35. Wadia, J. S.; Dowdy, S. F. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv. Drug Deliv. Rev. 57:579-596; 2005.
36. Selivanova, G.; Iotsova, V.; Okan, I.; Fritsche, M.; Strom, M.; Groner, B.; Grafstrom, R. C.; Wiman, K. G. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nat. Med. 3:632-638; 1997.
37. Harbour, J. W.; Worley, L.; Ma, D.; Cohen, M. Transducible peptide therapy for uveal melanoma and retinoblastoma. Arch. Ophthalmol. 120:1341-1346; 2002.
38. Snyder, E. L.; Meade, B. R.; Saenz, C. C.; Dowdy, S. F. Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide. PLoS Biol. 2:E36; 2004.
39. Nagahara, H.; Vocero-Akbani, A. M.; Snyder, E. L.; Ho, A.; Latham, D. G.; Lissy, N. A.; Becker-Hapak, M.; Ezhevsky, S. A.; Dowdy, S. F. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4:1449-1452; 1998.
40. Parada, Y.; Banerji, L.; Glassford, J.; Lea, N. C.; Collado, M.; Rivas, C.; Lewis, J. L.; Gordon, M. Y.; Thomas, N. S.; Lam, E. W. BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression. J. Biol. Chem. 276:23572-23580; 2001.
41. Goldberg, E. P.; Hadba, A. R.; Almond, B. A.; Marotta, J. S. Intratumoral cancer chemotherapy and immunotherapy: Opportunities for nonsystemic preoperative drug delivery. J. Pharm. Pharmacol. 54:159-180; 2002.
42. Springate, C. M.; Jackson, J. K.; Gleave, M. E.; Burt, H. M. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models. Cancer Chemother. Pharmacol. 56:239-247; 2005.
43. Boiardi, A.; Bartolomei, M.; Silvani, A.; Eoli, M.; Salmaggi, A.; Lamperti, E.; Milanesi, I.; Botturi, A.; Rocca, P.; Bodei, L.; Broggi, G.; Paganelli, G. Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma. J. Neurooncol. 72:125-131; 2005.
44. Chvapil, M.; Dorr, R. Single intratumoral injection of long-acting benzyl ester of D-penicillamine inhibits the growth of melanoma tumor in mice. Anticancer Drugs 16:757-762; 2005.
45. Laccabue, D.; Tortoreto, M.; Veneroni, S.; Perego, P.; Scanziani, E.; Zucchetti, M.; Zaffaroni, M.; D'Incalci, M.; Bombardelli, E.; Zunino, F.; Pratesi, G. A novel taxane active against an orthotopically growing human glioma xenograft. Cancer 92:3085-3092; 2001.
46. Ozawa, T.; Wang, J.; Hu, L. J.; Bollen, A. W.; Lamborn, K. R.; Deen, D. F. Growth of human glioblastomas as xenografts in the brains of athymic rats. In Vivo 16:55-60; 2002.